|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 10/12/14 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
| 09/12/14 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +1.00% | +4.39% | +21.55% | +11.96% | +4.42% | +43.53% | -0.30% | +29.00% | +90.60% | 79.68B | |
| +0.97% | +4.90% | +12.11% | +8.39% | -7.73% | -0.37% | +26.99% | +4.65% | - | 50.61B | |
| -1.22% | -4.41% | -7.59% | -9.20% | -8.17% | +17.13% | +167.13% | +123.57% | +218.83% | 48.81B | |
| -0.66% | +5.25% | +11.90% | +39.54% | -20.35% | -47.97% | -48.32% | -52.68% | +18.04% | 46.91B | |
| +0.85% | +2.12% | +0.78% | +2.99% | +19.69% | +55.82% | -22.77% | -38.45% | -32.78% | 30.86B | |
| -0.03% | +18.18% | -5.01% | +26.24% | +115.84% | +136.71% | -36.35% | -83.67% | - | 25.42B | |
| -0.21% | +1.81% | +5.51% | +21.96% | +22.02% | +40.38% | +84.73% | +64.04% | +49.62% | 24.48B | |
| -0.42% | +5.37% | +6.08% | +7.27% | +24.79% | +8.99% | +187.03% | +33.45% | - | 21.2B | |
| -3.14% | -1.92% | -2.25% | +18.36% | +6.17% | +61.19% | +157.40% | +62.03% | - | 16.39B | |
| +0.85% | +1.77% | -4.80% | +2.14% | +34.80% | +63.13% | +111.21% | +153.73% | +341.97% | 16.18B | |
| 0.00% | +14.62% | +27.39% | +20.69% | -8.18% | -5.01% | +768.95% | +497.47% | +6,202.86% | 15.6B | |
| -2.43% | +11.50% | +15.76% | +27.97% | +15.31% | +17.55% | -24.10% | -8.66% | -26.40% | 13.6B | |
| -0.46% | +1.69% | -6.40% | -9.20% | +17.00% | +95.34% | +198.23% | +834.73% | +2,948.22% | 11.24B | |
| -1.36% | +1.75% | -9.66% | +5.04% | +33.18% | +119.86% | +173.07% | +484.44% | - | 9.85B | |
| +0.06% | +14.86% | +38.67% | +130.35% | +294.99% | +337.31% | +470.54% | +24.65% | - | 7.85B | |
| +0.74% | -0.59% | +13.99% | +16.67% | -5.14% | -18.11% | -22.46% | -51.15% | -48.32% | 6.96B | |
| +0.36% | +10.06% | +16.56% | +30.99% | +13.82% | +27.00% | +83.17% | +0.64% | - | 6.81B | |
| +1.69% | +10.78% | -9.89% | -4.51% | +15.82% | +37.98% | +269.73% | +236.54% | - | 6.22B | |
| -0.41% | +1.73% | +27.72% | +31.65% | +88.68% | +131.29% | +357.82% | +535.87% | - | 6.1B | |
| Average | -0.17% | +3.84% | +8.02% | +19.96% | +34.58% | +59.04% | +152.72% | +150.01% | +976.26% | 22.24B | |
| Weighted average by Cap. | +0.02% | +3.27% | +8.23% | +15.14% | +16.86% | +37.31% | +89.02% | +78.59% | +522.28% |
- Stock Market
- Stocks
- Stock
- Sector Cubist Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
